Smith J. Jefferson
Chief Research Officer at DTIL
- Sold, on record
- $123k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Feb 18, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- DTILPRECISION BIOSCIENCES INCChief Research Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice DTILNoticeJun 10, 2024 2024
Filed to sell 50 shares ($589)
Smith J. Jefferson, Officer
No 10b5-1 planFiling
- 2 Form 4 sale DTILNo planJun 10, 2024 same day
Sold 50 shares at $11.79 ($590)
Smith J. Jefferson, Chief Research Officer
No 10b5-1 planSold 0.1% of holdings ($809k position)68,559 shares leftFollows a Form 144Filing
- 3 Form 144 notice DTILNoticeJan 22, 2025 +226 days
Filed to sell 10,287 shares ($49k)
Smith J. Jefferson, Officer
No 10b5-1 plan66.8x usual sizeFiling
- 4 Form 4 sale DTILUnusualJan 22, 2025 same day
Sold 10,287 shares at $4.79 ($49k)
Smith J. Jefferson, Chief Research Officer
10b5-1 planSold 10.5% of holdings ($468k position)87,440 shares left66.8x usual sizeFollows a Form 144Filing
- 5 Form 144 notice DTILNoticeMar 4, 2025 +41 days
Filed to sell 154 shares ($756)
Smith J. Jefferson, Officer
No 10b5-1 plan0x usual sizeFiling
- 6 Form 4 sale DTILRoutineMar 4, 2025 same day
Sold 154 shares at $4.91 ($756)
Smith J. Jefferson, Chief Research Officer
10b5-1 planSold 0.2% of holdings ($432k position)87,805 shares left0x usual sizeFollows a Form 144Filing
- 7 Form 4 sale DTILUnusualJan 21, 2026 +323 days
Sold 10,200 shares at $4.03 ($41k)
Smith J. Jefferson, Chief Research Officer
10b5-1 planSold 8.5% of holdings ($485k position)110,184 shares left66.2x usual sizeFiling
- 8 Form 4 sale DTILUnusualFeb 18, 2026 +28 days
Sold 4,925 shares at $3.84 ($19k)
Smith J. Jefferson, Chief Research Officer
10b5-1 planSold 3.9% of holdings ($487k position)121,926 shares left32x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Feb 19, 2026 | DTIL | Chief Research Officer | Form 4 sale | 4,925 | $19k | 3.9% | Unusual | SEC |
| Jan 21, 2026 | Jan 22, 2026 | DTIL | Chief Research Officer | Form 4 sale | 10,200 | $41k | 8.5% | Unusual | SEC |
| Mar 4, 2025 | Mar 5, 2025 | DTIL | Chief Research Officer | Form 4 sale | 154 | $756 | 0.2% | Routine | SEC |
| Mar 4, 2025 | Mar 4, 2025 | DTIL | Officer | Form 144 notice | 154 | $756 | Notice | SEC | |
| Jan 22, 2025 | Jan 22, 2025 | DTIL | Chief Research Officer | Form 4 sale | 10,287 | $49k | 10.5% | Unusual | SEC |
| Jan 22, 2025 | Jan 22, 2025 | DTIL | Officer | Form 144 notice | 10,287 | $49k | Notice | SEC | |
| Jun 10, 2024 | Jun 11, 2024 | DTIL | Chief Research Officer | Form 4 sale | 50 | $590 | 0.1% | No plan | SEC |
| Jun 10, 2024 | Jun 10, 2024 | DTIL | Officer | Form 144 notice | 50 | $589 | Notice | SEC | |
| May 2, 2024 | May 3, 2024 | DTIL | Chief Research Officer | Form 4 sale | 154 | $2k | 0.2% | No plan | SEC |
| May 2, 2024 | May 2, 2024 | DTIL | Officer | Form 144 notice | 154 | $2k | Notice | SEC | |
| Jan 23, 2024 | Jan 23, 2024 | DTIL | Officer | Form 144 notice | 28,000 | $10k | Notice | SEC | |
| Jan 23, 2024 | Jan 23, 2024 | DTIL | Chief Research Officer | Form 4 sale | 28,000 | $10k | 1.4% | No plan | SEC |